Iñigo Tirapu
- Immunology top 5%
- Immunotherapy and Immune Responses 23
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 8
- Phagocytosis and Immune Regulation 3
- Oncology top 5%
- CAR-T cell therapy research 13
- Cancer Immunotherapy and Biomarkers 6
- Biotechnology top 10%
- Orthopedics and Sports Medicine top 10%
-
- Virus-based gene therapy research 5
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Ignacio MeleroJesús PrìetoAinhoa ArinaGuillermo MazzoliniCarlos AlfaroEsperanza FeijoóOihana MurilloCheng Qian
- Cited by
- ImmunologyOncologyBiotechnology
- Journals
- Molecular Therapy (3 papers)OncoImmunology (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- SpainUnited StatesAustria
In The Last Decade
Iñigo Tirapu
32 papers receiving 863 citations
Peers
Comparison fields: 5 of 71
- Immunology 559
- Oncology 457
- Biotechnology 50
- Orthopedics and Sports Medicine 49
- Genetics 127
Countries citing papers authored by Iñigo Tirapu
This map shows the geographic impact of Iñigo Tirapu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iñigo Tirapu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iñigo Tirapu more than expected).
Fields of papers citing papers by Iñigo Tirapu
This network shows the impact of papers produced by Iñigo Tirapu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iñigo Tirapu. The network helps show where Iñigo Tirapu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iñigo Tirapu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2020 | 23 | |
| 4 | 2020 | 48 | |
| 5 | 2009 | 12 | |
| 6 | 2009 | 60 | |
| 7 | 2007 | 14 | |
| 8 | 2006 | 116 | |
| 9 | 2006 | 4 | |
| 10 | 2006 | 39 | |
| 11 | 2005 | 5 | |
| 12 | 2005 | 10 | |
| 13 | 2005 | 90 | |
| 14 | 2004 | 61 | |
| 15 | Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death. | 2003 | 7 |
| 16 | An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas. | 2002 | 17 |
| 17 | 2002 | 27 | |
| 18 | 2002 | 33 | |
| 19 | 2002 | 19 | |
| 20 | 2001 | 3 |
About Iñigo Tirapu
Iñigo Tirapu is a scholar working on Immunology, Oncology and Genetics, having authored 32 papers that have together received 888 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Virus-based gene therapy research (5 papers), Phagocytosis and Immune Regulation (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology (559 citations), Oncology (457 citations) and Biotechnology (50 citations). Iñigo Tirapu has collaborated with scholars based in Spain, United States and Austria. Frequent co-authors include Ignacio Melero, Jesús Prìeto, Ainhoa Arina, Guillermo Mazzolini, Carlos Alfaro, Esperanza Feijoó, Oihana Murillo, Cheng Qian, Eduardo Huarte and Lieping Chen. Their work appears in journals such as Molecular Therapy, OncoImmunology, International Journal of Cancer, Cancer Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.